Aurobindo gets approval for Exelon generic
Aurobindo Pharma Ltd. has received final approval from the Food and Drug Administration for rivastigmine tartrate capsules, a dementia medication, in dosages of 1.5 mg, 3 mg, 4.5 mg and 6 mg. Aurobindo said Monday that its rivastigmine tartrate product (1.5 mg, 3 mg, 4.5 mg and 6 mg) is a generic